Preconception care for improving perinatal outcomes: The time to act

Maternal and Child Health Journal

Volumn 10, Issue 1, 2006, Pages 3-11

  Atrash, Hani K ^a   Johnson, Kay ^b   Adams, Myron ^a   Cordero, José F ^a   Howse, Jennifer ^c  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c March of Dimes   (United States)

Author keywords

Perinatal outcomes; Preconception care; Women's health

Indexed keywords

ALCOHOL; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; FOLIC ACID; HEPATITIS B VACCINE; ISOTRETINOIN; LEVOTHYROXINE; NON PRESCRIPTION DRUG; RUBELLA VACCINE; WARFARIN;

ACNE; ARTICLE; BIRTH DEFECT; BLOOD CLOTTING DISORDER; CHILD HEALTH CARE; CONGENITAL RUBELLA SYNDROME; DRUG CONTRAINDICATION; FEMALE; FETOTOXICITY; FETUS MORTALITY; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH PROMOTION; HEPATITIS B; HUMAN; HYPOTHYROIDISM; INFANT MORTALITY; LOW BIRTH WEIGHT; MATERNAL CARE; MEDICAID; MEDICAL ASSESSMENT; MEDICAL SOCIETY; PERINATAL CARE; PRACTICE GUIDELINE; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; TERATOGENICITY; VERTICAL TRANSMISSION; VITAMIN SUPPLEMENTATION;

EID: 33748692412     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-006-0100-4     Document Type: Article

References (90)

1. United States Department of Health, Education, and Welfare. Infant, fetal, and maternal mortality: United States-1963. Washington, DC: The Department; 1966.
2. United States Department of Health and Human Services. Health United States, 2004. Hyattsville, MD: The Department; 2004.
3. Centers for Disease Control and Prevention. Healthier mothers and babies. MMWR 1999;48:849-58.
4. Centers for Disease Control and Prevention. Birth: Final data for 2002. National Vital Statistics Reports 2003;52.
5. Correa-Villasenor A, et al. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res 2003;67:617-24.
6. Centers for Disease Control and Prevention. Advance report of final mortality statistics, 1980. Monthly Vital Statistics Report 1983;32 Suppl.
7. Centers for Disease Control and Prevention. Deaths: Leading causes for 2002. National Vital Statistics Reports 2005;53.
8. Danel I, et al. Magnitude of maternal morbidity during labor and delivery: United States, 1993-1997. Am J Public Health 2003;93:631-4.
9. United States Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau. Women's health USA 2002. Rockville, MD: The Department; 2004.
10. Centers for Disease Control and Prevention. Alcohol consumption among women who are pregnant or who might become pregnant-United States, 2002. MMWR 2004;53:1178
11. Besculides M, Laraque F. Racial and ethnic disparities in perinatal mortality: Applying the perinatal periods of risk model to identify areas for intervention. JAMA 2005;97:1128-32.
12. Cai J, Hoff GL, Dew PC, Guillory VJ, Manning J. Perinatal periods of risk: Analysis of fetal-infant mortality rates in Kansas City, Missouri. Matern Child Health J 2005;9:199-205.
13. Burns PG. Reducing infant mortality rates using the perinatal periods of risk model. Public Health Nurs 2005;22:2-7.
14. March of Dimes Birth Defects Foundation. March of Dimes Updates: Is early prenatal care too late? Contemp Ob/Gyn 2002;12:54-72.
15. American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. In: Gilstrap L, Oh W, editors. Guidelines for perinatal care. 5th ed. Washington, DC, 2002.
16. Korenbrot CC, et al. Preconception care: A systematic review. Mater Child Health J 2002;6:75-88.
17. United States Public Health Service. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992;41(RR14).
18. Centers for Disease Control and Prevention. Effectiveness in disease and injury prevention use of folic acid for prevention of spina bifida and other neural tube defects - 983-1991. MMWR 1991;40:513-6.
19. United States Preventive Services Task Force. Screening for neural tube defects. Guide to clinical preventive services. 2nd ed. 1996, pp. 473-6.
20. American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists. Committee Opinion No. 44 (replaces Committee Opinion No. 252, March 2001). Obstet Gynecol 2003;102:203-13.
21. American College of Obstetricians and Gynecologists Committee on Obstetrics: Maternal and Fetal Medicine. Folic acid for the prevention of recurrent neural tube defects. Committee Opinion No. 120, March 1993. Int J Gynaecol Obstet 1993;42:75-7.
22. Institute of Medicine Food and Nutrition Board. Dietary reference intakes for folate and other B vitamins. Washington, DC: National Academies Press; 1998.
23. Institute of Medicine Food and Nutrition Board. Dietary reference intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic acid, Biotin, and Choline. Washington, DC: National Academies Press; 2000.
24. Lumley J, et al. Periconceptional supplementation with folate and(or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 2001;CD001056.
25. Centers for Disease Control and Prevention. Control and prevention of rubella: Evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR 2001;50(RR12).
26. United States Preventive Services Task Force. Screening for rubella. Guide to clinical preventive services. 2nd ed. 1996.
27. American College of Obstetricians and Gynecologists. Rubella vaccination. Committee opinion no. 281, December 2002. Int J Gynaecol Obstet 2003;81:241.
28. American Diabetes Association. Preconceptional care of women with diabetes. Diabetes Care 2004;27 Suppl:S76-8.
29. Kitzmiller JL et al. Preconception care of diabetes, congenital malformations, and spontaneous abortions (technical review). Diabetes Care 1996;19:514-41.
30. American College of Obstetricians and Gynecologists Committee on Technical Bulletins. Diabetes and pregnancy. Technical Bulletin No. 200, December 1994 (replaces No. 92, May 1986). Int J Gynaecol Obstet 1995;48:31-9.
31. Centers for Disease Control and Prevention. Strategies for reducing morbidity and mortality from diabetes through health-care system interventions and diabetes self-management education in community settings. MMWR 2001;50(RR16).
32. Helfand M, United States Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: A summary of the evidence for the United States Preventive Services Task Force. Ann Intern Med 2004;40:128-41.
33. American College of Obstetricians and Gynecologists. Thyroid disease in pregnancy. Clinical management guidelines for Obstetrician-Gynecologists. Practice bulletin no. 37, August 2002. Obstet Gynecol 2002;100:387-96.
34. American Association of Clinical Endocrinologists, AACE Thyroid Task Force. Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Prac 2002;8:457-69.
35. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. Revised recommendations for HIV screening of pregnant women. MMWR 2001;50(RR19).
36. United States Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR 2002;51(RR18):1-38.
37. American College of Obstetricians and Gynecologists. Human immunodeficiency virus infections in pregnancy. Int J Gynaecol Obstet 1997;57:73-80.
38. American College of Obstetricians and Gynecologists Committee on Ethics. Human immunodeficiency virus: Ethical guidelines for obstetricians and gynecologists. Obstet Gynecol 2001;97 Suppl:1-6.
39. Institute of Medicine. Reducing the odds: Preventing perinatal transmission of HIV in the United States. Washington, DC: National Academy Press; 1999.
40. Institute of Medicine. Make prenatal HIV testing part of routine care. AIDS Alert 1998;13:137-8.
41. Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2002;CD003510.
42. Phenylketonuria: Screening and Management. NIH Consensus Statement HOnline 2000 October 16-18:17, 1-27. Available at: URL: http://consensus.nih.gov/2000/2000Phenylketonuria113html.htm
43. American College of Obstetricians and Gynecologists Committee on Genetics. Maternal phenylketonuria. Int J Gynaecol Obstet 2001;72:83-4.
44. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. Thrombembolism in pregnancy. Int J Gynaecol Obstet 2001;75:203-12.
45. American College of Obstetricians and Gynecologists. Preventing deep venous thrombosis and pulmonary embolism. Am Fam Physician 2001;63:2279-80.
46. Hirsh J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;107: 692-711.
47. American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy Educational bulletin no. 231. Int J Gynec Obstet 1997;56:279-86.
48. Barrett C, Richens A. Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop. Epilepsy Res 2003;52:147-87.
49. Crawford P, et al. Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group. Seizure 1999;8:201-17.
50. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: Management issues for women with epilepsy (summary statement). Neurology 1998;51:944-8.
51. Morrell MJ. Guidelines for the care of women with epilepsy-Consensus conference-Current clinical practice. Neurology 1998;51Suppl:S21-7.
52. Centers for Disease Control and Prevention. Accutane-exposed pregnancies-California, 1999. MMWR 2000;49:28-31.
53. Perlman SE, et al. Caring for women with childbearing potential taking teratogenic dermatologic drugs-guidelines for practice. J Reprod Med 2001;46Suppl:153-61.
54. Perlman SE, et al. "Be smart, be safe, be sure." The revised Pregnancy Prevention Program for women on isotretinoin. J Reprod Med 2001;46Suppl:179-85.
55. United States Department of Health and Human Services, Public Health Service. Clinical Practice Guideline: Treating tobacco use and dependence. Washington, DC: The Department; 2000.
56. United States Preventive Services Task Force. Counseling: Tobacco use Guide to Preventive Services, 3rd edition, Periodic Updates. Available Hat: URL: http://www.ahrq.gov/clinic/uspstf/uspstbac.htm
57. Hopkins DP, et al. Task Force on Community Preventive Services. Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med 2001;20Suppl:16-66.
58. American College of Obstetricians and Gynecologists. Smoking cessation during pregnancy. Educational bulletin no. 260, September 2000. Int J Gynaecol Obstet 2001;75:345-8.
59. Weber MK, et al. National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect. Defining the national agenda for fetal alcohol syndrome and other prenatal alcohol-related effects. MMWR 2002;51(RR14):9-12.
60. United States Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med 2004;140:554-6.
61. Whitlock EP, et al. United States Preventive Services Task Force. Behavioral counseling interventions in primary care to reduce risky(harmful alcohol use by adults: A summary of the evidence for the United States Preventive Services Task Force. Ann Intern Med 2004;40:557-68.
62. American College of Obstetricians and Gynecologists. Substance abuse in pregnancy. Technical Bulletin No. 195, July 1994 (replaces No. 96, September 1986). Int J Gynaecol Obstet 1994;47:73-80.
63. Stratton K, Howe C, Battaglia FC, editors, Committee to Study Fetal Alcohol Syndrome. Institute of Medicine. Fetal Alcohol Syndrome: Diagnosis, epidemiology, prevention, and treatment. Washington, DC: National Academies Press; 1996.
64. Bonnie RJ, O'Connell ME, editors; Committee on Developing a Strategy to Reduce and Prevent Underage Drinking. Institute of Medicine. Reducing Underage Drinking: A collective responsibility. Washington, DC: National Academies Press; 2004.
65. United States Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute Obesity Education Initiative. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda (MD): The Department, 1998. NIH Publication No. 98-4083.
66. United States Preventive Services Task Force. Screening for obesity in adults: Recommendations and rationale. Ann Intern Med 2003;139:930-2.
67. Institute of Medicine. Subcommittee on nutritional status and weight gain during pregnancy. Washington, DC: National Academy Press; 1990.
68. Kramer MS. Energy/protein restriction for high weight-for-height or weight gain during pregnancy. Cochrane Database Syst Rev 2000;CD000080.
69. American College of Preventive Medicine Practice. Policy statement: weight management counseling of overweight adults. Am J Prev Med 2001;21:73-8.
70. Centers for Disease Control and Prevention. Chlamydia trachomatis genital infections-United States, 1995. MMWR 1997;46:193-8.
71. Centers for Disease Control and Prevention. Gonorrhea-United States, 1998. MMWR 2000;49:538-42.
72. Centers for Disease Control and Prevention. Hepatitis B vaccination-United States, 1982-2002. MMWR 2002;51:549-52, 63.
73. Gunn RA, et al. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program. Am J Prev Med 2005;29:27-33.
74. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate the transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part immunization of infants, children, and adolescents. MMWR 2005;54(RR-16):1-23.
75. Czeizel AE. Ten years of experience in periconceptional care. Eur J Obstet Gynecol Reprod Biol 1999;84:43-9.
76. Moos MK. Preconceptional wellness as a routine objective for women's health care: An integrative strategy. J Obstet Gynecol Neonatal Nurs 2003;32:550-6.
77. Jack BW, et al. Addressing preconception risks identified at the time of a negative pregnancy test. A randomized trial. J Fam Pract 1998;47:33-8.
78. Rodgers BD, Rodgers DE. Efficacy of preconception care of diabetic women in a community setting. J Reprod Med 1996;41:422-6.
79. Lomas J. Retailing Research: Increasing the role of evidence in clinical services for childbirth. Milbank Q 1993;71:439-76.
80. Barash JH, Weinstein LC. Preconception and prenatal care. Prim Care 2002;29:519-42.
81. Brundage SC. Preconception health care. Am Fam Physician 2002;65:2507-14.
82. Henderson JT, et al. The role of physician gender in the evaluation of the National Centers of Excellence in Women's Health: Test of an alternate hypothesis. Women's Health Issues 2004;14:130-9.
83. Kaiser Family Foundation. Women and health care: Key findings from the women's health survey. Washington, DC: The Foundation; 2005.
84. Kaiser Family Foundation. Women's Health Policy Fact Sheet: Women's Health Insurance Coverage, November 2004.
85. Kaiser Family Foundation. Medicaid's Role for Women. Issue Brief on Women's Health Policy, November 2004.
86. Edwards J, Bronstein J, Adams K. Evaluation of Medicaid Family Planning Demonstrations. The CAN Corporations Contract No. 752-2-415921. Sponsored by the Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services.
87. National Association of State Medicaid Directors. Review of Medicaid Family Planning Expansion Waivers, 2004. Available at: URL: www.nasmd.org.
88. USPHS- US Public Health Service Expert Panel on the Content of Prenatal Care. Caring for Our Future: The Content of Prenatal Care. Washington, DC: US Dept of Health and Human Services, 1989.
89. Petrie K, Frey KA, editors. Preconception Care/Infertility. Kansas City, Mo: American Academy of Family Physicians, 1998. Monograph 234.
90. Spring B, Pagoto S, Pingitore R, Doran N, Schneider K, Hedeker D. Randomized controlled trial for behavioral smoking and weight control treatment: Effect of concurrent versus sequential intervention. J Consult Clin Psychol 2004;72:785-96.